Close Menu
Free Consultation: 888-976-6111

Options Overlay Complaints Against UBS Rep Michael Sherman

Financial Industry Regulatory Authority (FINRA) records list several customer complaints connected to New York City-based UBS Financial Services broker and adviser Michael Sherman (CRD# 1031880). The complaints detail allegations concerning an options overlay strategy recommended by the firm, and cumulatively settled for more than $700,000. 

A complaint filed in October 2019 alleges that an options overlay strategy investment was misrepresented and unsuitable for the client. The complaint lists the time frame of the investment as “2018-present” and reached a settlement of $200,000. Michael Sherman’s “Broker Comment” on the disclosure states in part: “This is an arbitration against UBS Financial. This filing relates to the Yield Enhancement Strategy operated by a separate UBS team in New York City.” It goes on to state that his office did not manage the investment, and that it was presented to the clients as it was presented to his office by the New York UBS team. 

A June 2019 complaint details similar allegations about the options strategy, specifically that it was misrepresented and not suitable for the customer. This complaint lists the investment’s time frame as “2016-present” and reached a settlement of $335,000. Sherman’s comment on the disclosure reiterates that the complaint concerns an investment operated by a separate team within the firm, and states that he is “not named in the arbitration.” 

A third complaint about the UBS options strategy was filed in June 2019, concerning a time frame from 2016 until the present. This complaint also alleges that the strategy was unsuitable and misrepresented by UBS. It reached a settlement of $200,000. Sherman’s comment on this disclosure also states that the presented the investment to the clients as it was presented to his firm by the UBS team in New York City, and emphasizes that he is “not named in the arbitration.”

Michael Sherman has been registered with UBS Financial Services in New York, New York and Bristol, Maine since 2009. His registration history includes Citigroup Global Markets in Westport, Connecticut, where he was registered from 2003 until 2009; AG Edwards & Sons in Darien, Connecticut, where he was registered from 1998 until 2003; AG Edwards & Sons in St. Louis, Missouri, where he was registered from 1984 until 2003; and Painewebber, where he was registered from 1982 until 1984. He has passed six securities industry examinations, including the Uniform Investment Adviser Law Examination (Series 65), Uniform Securities Agent State Law Examination (Series 63),  and National Commodity Futures Examination (Series 3). His BrokerCheck report lists 24 state securities licenses. (Information current as of May 11, 2022.)

Carlson Law represents investors throughout the United States in claims against financial advisors and investment firms. If you or a loved one have suffered investment losses, please call us at 888-976-6111 or complete our contact form for a free and confidential consultation.

Facebook Twitter LinkedIn
Contact Us For A Free Case Evaluation
protected by reCAPTCHA Privacy - Terms
Latest Blog Posts
  • Robert Wise: Wells Fargo Advisor Faces $1 Million Complaint

    Tampa, Florida financial advisor Robert Wise (CRD# 5884184) recently received an investor complaint alleging that his advice resulted in seven-figure...

    Read More
  • Brett Wooten: $365K Complaint Against Landmark Financial Advisor

    Smyrna, Georgia financial advisor Brett Wooten (CRD# 5928719) recently received an investor complaint alleging more than $300,000 in damages. Financial...

    Read More
  • Brittani Schaefer: Ex-Arete Advisor Faces $100K Complaint

    Creve Couer, Missouri financial advisor Brittani Schaefer (CRD# 6327801) recently received an investor complaint alleging six-figure damages. Financial Industry Regulatory...

    Read More
  • Stephen Fortin: $70K Oil & Gas Complaint Against Ex-Lincoln Advisor

    Cincinnati, Ohio financial advisor Stephen Fortin (CRD# 2320006) allegedly recommended an unsuitable investment, according to a recent investor complaint. Financial...

    Read More
  • Previous
  • Next